肺炎链球菌：β-内酰胺类、氟喹诺酮类和大环内酯类抗菌药物耐药性的演变。
Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides.
机构信息
Malawi-Liverpool-Wellcome Clinical Research Programme, PO Box 30096, Chichiri, Blantyre 3, Malawi.
出版信息
Microbes Infect. 2012 Jul;14(7-8):573-83. doi: 10.1016/j.micinf.2012.01.012. Epub 2012 Feb 4.
PMID:22342898
Abstract
Multi drug resistant Streptococcus pneumoniae constitute a major public health concern worldwide. In this review we discuss how the transformable nature of the pneumococcus, in parallel with antimicrobial induced stress, contributes to the evolution of antimicrobial resistance; and how the introduction of the pneumococcal conjugate vaccine has affected the situation.
摘要
耐多药肺炎链球菌是全球主要的公共卫生关注点。在这篇综述中，我们讨论了肺炎链球菌的可转化特性，以及与抗菌药物诱导的应激并行，如何促进抗菌药物耐药性的演变；以及肺炎球菌结合疫苗的引入如何影响了这一情况。
Zotero 插件